ADMA Biologics Inc (ADMA)
Fixed asset turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 426,454 | 382,809 | 330,245 | 283,177 | 258,216 | 234,293 | 208,108 | 181,890 | 154,079 | 130,481 | 110,072 | 93,998 | 80,944 | 68,517 | 58,112 | 48,069 | 42,220 | 40,301 | 37,248 | 36,021 |
Property, plant and equipment | US$ in thousands | 54,707 | 53,694 | 54,326 | 55,317 | 53,835 | 54,815 | 56,306 | 57,371 | 58,261 | 56,946 | 54,951 | 53,220 | 50,935 | 48,394 | 46,487 | 44,176 | 41,593 | 39,623 | 37,373 | 35,061 |
Fixed asset turnover | 7.80 | 7.13 | 6.08 | 5.12 | 4.80 | 4.27 | 3.70 | 3.17 | 2.64 | 2.29 | 2.00 | 1.77 | 1.59 | 1.42 | 1.25 | 1.09 | 1.02 | 1.02 | 1.00 | 1.03 |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $426,454K ÷ $54,707K
= 7.80
The fixed asset turnover ratio for ADMA Biologics Inc has been showing a consistent increasing trend over the periods reported. The ratio has grown from 1.03 in March 2020 to 7.80 in December 2024. This indicates that the company is generating more revenue per dollar invested in fixed assets. The increasing trend suggests improved efficiency in utilizing its fixed assets to generate sales, which is a positive sign of operational performance. It shows that ADMA Biologics Inc has been successful in effectively managing and utilizing its fixed assets over time to drive revenue growth.
Peer comparison
Dec 31, 2024